Psychiatry and Neurology, Neurology · Toledo, OH
NPI
1396278586
Since 2017
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3000 Arlington Ave Ste 2c
Toledo, OH, 43614
Phone (419) 383-3759
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
575 services
Medicare patients, 2024
260
Average age 74
Drug cost, 2024
$1.3M
3,169 prescriptions
Company payments, 2025
$9,943
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jennifer Amsdell was code 99214 (office e&m - established), 175 times for 121 patients. In total Jennifer Amsdell billed 575 services in 16 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 175 | 121 | $83.14 | $15K |
| 99213 Office E&M - Established | Office | 129 | 100 | $56.66 | $7,309 |
| 99232 Hospital E&M - Subsequent | Facility | 44 | 24 | $59.25 | $2,607 |
| 95970 Electrical Nerve Conductivity | Office | 20 | 14 | $13.38 | $268 |
| 95983 Electrical Nerve Conductivity | Office | 20 | 12 | $29.76 | $595 |
| 99221 Hospital E&M - Initial | Facility | 19 | 19 | $53.61 | $1,019 |
By year: 2022 $35K for 458 services; 2023 $45K for 671 services; 2024 $34K for 575 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jennifer Amsdell prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 679 prescriptions and refills. In total Jennifer Amsdell wrote 3,169 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 679 | 1,573 | 185 | $29K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 443 | 1,023 | 118 | $41K |
| Gabapentin Generic | 157 | 246 | 37 | $3,220 |
| Rasagiline Mesylate Generic | 129 | 302 | 33 | $38K |
| Amantadine Amantadine Hcl | 123 | 292 | 40 | $6,177 |
| Rytary Carbidopa/Levodopa | 101 | 161 | 20 | $114K |
| Rivastigmine Generic | 98 | 176 | 22 | $28K |
| Donepezil Hcl Generic | 80 | 160 | 21 | $724 |
| Primidone Generic | 75 | 154 | 17 | $3,524 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 70 | 172 | 25 | $1,891 |
| Ropinirole Er Ropinirole Hcl | 70 | 138 | 14 | $13K |
| Quetiapine Fumarate Generic | 70 | 127 | 16 | $1,277 |
| Clonazepam Generic | 64 | 98 | 17 | $779 |
| Topiramate Generic | 61 | 145 | 16 | $790 |
| Ropinirole Hcl Generic | 58 | 123 | 16 | $1,465 |
Brand drugs: 343 claims; generic drugs: 2,826 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jennifer Amsdell $9,943 ($9,943 in general payments such as food, travel and fees) from 17 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $8,392.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 12 | $8,392 |
| Abbvie Inc. ABBV | 26 | $538 |
| UCB, Inc. UCB.BR | 10 | $164 |
| Abbott Laboratories ABT | 2 | $156 |
| Medtronic, Inc. MDT | 4 | $152 |
| SK Life Science, Inc. | 7 | $128 |
| Boston Scientific Corporation BSX | 1 | $77.39 |
| TG Therapeutics, Inc. TGTX | 3 | $74.32 |
| Neurelis, Inc. | 4 | $72.36 |
| ACADIA Pharmaceuticals Inc ACAD | 3 | $44.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.